Table 1 MAP-specific antibodies in serum and MAP antigen detection in feces and blood
Days post inoculation (d) | Fecal samples | Blood samples | Serum samples | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Group B | Group C | Group B | Group C | Group B | Group C | |||||||||||||
4 | 5 | 6 | 7 | 8 | 9 | 4 | 5 | 6 | 7 | 8 | 9 | 4 | 5 | 6 | 7 | 8 | 9 | |
1 |  +  |  +  |  +  |  +  |  +  |  +  | * | * | * | * | * | * | * | * | * | * | * | * |
2 |  +  |  +  |  +  |  +  |  +  |  +  | * | * | * | * | * | * | * | * | * | * | * | * |
3 |  +  |  +  |  +  |  +  |  +  |  +  | * | * | * | * | * | * | * | * | * | * | * | * |
60 | – | – | – |  +  | – | – | – |  +  | – | – | – | – | – | – | – | – | – | – |
75 |  +  | – | – | – | – |  +  | – | – | – | – | – | – | – | – | – | – | – |  +  |
90 | – |  +  | – |  +  |  +  | – | – | – | – | – | – | – | – | – | – |  +  | – | – |
105 |  +  | – |  +  |  +  | – |  +  |  +  | – |  +  |  +  |  +  |  +  | – | – | – | – | – | – |
120 | – |  +  | – |  +  |  +  |  +  | – | – | – | – |  +  |  +  | – | – | – | – | – | – |
135 |  +  |  +  | – | – |  +  | – | – | – | – |  +  |  +  | – | – | – | – | – | – | – |
150 | – |  +  |  +  |  +  |  +  |  +  | – | – | – |  +  | – | – | – | – | – |  +  | – | – |
165 | – |  +  | – |  +  | – |  +  | – | – | – |  +  | – | – | – | – | – | – | – | – |
180 | – |  +  | – | – | – | – | – | – |  +  | – | – | – | – | – | – | – | – |  +  |
195 |  +  |  +  | – |  +  |  +  |  +  | – | – | – | – | – | – | – | – | – | – | – |  +  |
210 | – | – | – | – |  +  |  +  | – | – | – | – | – | – | – | – | – | – | – |  +  |
225 |  +  |  +  | – | – |  +  |  +  | – | – | – | – | – | – | – | – | – | – | – |  +  |
240 |  +  | – |  +  |  +  |  +  |  +  | – | – | – | – | – | – | – | – | – | – | – |  +  |
255 | – | – | – |  +  | – | – | – | – | – | – | – | – | – | – | – | – | – |  +  |
Positive rate (%) | 42.86 | 57.14 | 21.43 | 64.29 | 57.14 | 64.29 | 7.14 | 7.14 | 14.29 | 28.57 | 21.43 | 14.29 | 0 | 0 | 0 | 14.29 | 0 | 50 |